Melatonin for disordered sleep in individuals with autism spectrum disorders: Systematic review and discussion

Sleep Medicine Reviews

Volumn 15, Issue 6, 2011, Pages 379-387

  Guénolé, Fabian ^a   Godbout, Roger ^b   Nicolas, Alain ^c   Franco, Patricia ^d   Claustrat, Bruno ^e   Baleyte, Jean Marc ^a,f  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b Hopital Riviere des Prairies   (Canada)

^c Service Hospitalo Universitaire de Psychiatrie   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e Hopital Neuro Cardiologique   (France)

^f UNIVERSITÉ DE CAEN   (France)

Author keywords

Asperger syndrome; Autistic disorder; Child development disorder, pervasive; Circadian rhythm; Drug chronotherapy; Hypnotics and sedatives; Melatonin; Sleep; Sleep initiation and maintenance disorders

Indexed keywords

MELATONIN;

AUTISM; DAYTIME SOMNOLENCE; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; HEADACHE; HUMAN; MEDLINE; REVIEW; SLEEP DISORDER; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; HUMANS; MELATONIN; SLEEP DISORDERS; YOUNG ADULT;

EID: 82455171927     PISSN: 10870792     EISSN: 15322955     Source Type: Journal    
DOI: 10.1016/j.smrv.2011.02.001     Document Type: Review

References (90)

1. World Health Organization International classification of disease. Mental and behavioural disorders. Diagnostic criteria for research 1993, World Health Organization, Geneva, [chapter 5]. 10th ed.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders: text revision 2000, American Psychiatric Association, Washington, DC. 4th ed.
3. Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res 2009, 65:591-598.
4. Freitag C.M. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 2007, 12:2-22.
5. Schmitz C., Rezaie P. The neuropathology of autism: where do we stand?. Neuropathol Appl Neurobiol 2008, 34:4-11.
6. Miano S., Ferri R. Epidemiology and management of insomnia in children with autistic spectrum disorders. Pediatr Drugs 2010, 12:75-84.
7. Richdale A.L., Schreck K.A. Sleep problems in autism spectrum disorders: prevalence, nature, and possible biopsychosocial aetiologies. Sleep Med Rev 2009, 13:403-411.
8. Konstantareas M.M., Homatidis S. Assessing child symptom severity and stress in parents of autistic children. J Child Psychol Psychiatry 1989, 30:459-470.
9. Meltzer L.J. Sleep in parents of children with autism spectrum disorders. J Pediatr Psychol 2008, 33:380-386.
10. Doo S., Wing Y.K. Sleep problems of children with pervasive developmental disorders: correlation with parental stress. Dev Med Child Neurol 2006, 48:650-655.
11. Glickman G. Circadian rhythms and sleep in children with autism. Neurosci Biobehav Rev 2009.
12. Richdale A. Sleep in children with autism and Asperger syndrome. Sleep disturbance in children and adolescents with disorders of development: its significance and management 2001, 181-191. Mac Keith Press, London. G. Stores, L. Wiggs (Eds.).
13. Limoges E., Mottron L., Bolduc C., Berthiaume C., Godbout R. Atypical sleep architecture and the autism phenotype. Brain 2005, 128:1049-1061.
14. Tani P., Lindberg N., Nieminen-von Wendt T., von Wendt L., Alanko L., Appelberg B., et al. Insomnia is a frequent finding in adults with Asperger syndrome. BMC Psychiatry 2003, 3:12.
15. Richdale A.L., Prior M.R. The sleep/wake rhythm in children with autism. Eur Child Adolesc Psychiatry 1995, 4:175-186.
16. Patzold L.M., Richdale A.L., Tonge B.J. An investigation into sleep characteristics of children with autism and Asperger's disorder. J Paediatr Child Health 1998, 34:528-533.
17. Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Sring Harbor Symp Quart Biol 2007, 72:1-10.
18. Claustrat B., Brun J., Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev 2005, 9:11-24.
19. Brzezinski A., Vangel M.G., Wurtman R.J., Norrie G., Zhdanova I., Ben-Shushan A., et al. Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 2005, 9:41-50.
20. Buscemi N., Vandermeer B., Hooton N., Pandya R., Tjosvold L., Hartling L., et al. The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis. J Gen Intern Med 2005, 20:1151-1158.
21. Buscemi N., Vandermeer B., Hooton N., Pandya R., Tjosvold L., Hartling L., et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. Br Med J 2006, 332:385-393.
22. Hoffmann A., Farker K., Dittgen M., Hoffmann H. A melatonin preparation with a pulsatile liberation pattern: a new form of melatonin in replacement therapy. Biol Signals Recept 1999, 8:96-104.
23. Nir I., Meir D., Zilber N., Knobler H., Hadjez J., Lerner Y. melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord 1995, 25:641-654.
24. Kulman G., Lissoni P., Rovelli F., Roselli M.G., Brivio F., Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuroendocrinol Lett 2000, 21:31-34.
25. Tordjman S., Anderson G., Pichard N., Charbuy H., Touitou Y. Nocturnal excretion of 6-sulfatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry 2005, 57:134-138.
26. Melke J., Goubran-Botros H., Chaste P., Betancur C., Nygren G., Anckarsäter H., et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry 2008, 13:90-98.
27. Richdale A.L. Sleep problems in autism: prevalence, cause, and intervention. Dev Med Child Neurol 1999, 41:60-66.
28. Leu R.M., Beyderman L., Botzolakis E.J., Surdyka K., Wang L., Malow B.A. Relation of melatonin to sleep architecture in children with autism. J Autism Dev Disord 2010, 10.1007/s10803-010-1072-1.
29. Jan J.E., Freeman R.D. Melatonin therapy for circadian rhythm sleep disorders in children with multiple disabilities: what have we learned in the last decade?. Dev Med Child Neurol 2004, 46:776-782.
30. Doerry U., Kent L. Prescribing practices of community child and adolescent psychiatrists. Psychiatric Bull 2003, 27:407-410.
31. Bramble D., Feehan C. Psychiatrists' use of melatonin with children. Child Adolesc Ment Health 2005, 10:145-149.
32. Waldron D.L., Bramble D., Gringras P. Melatonin in children: prescribing practices and adverse events. Arch Dis Child 2005, 90:1207-1208.
33. Garstang J., Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev 2006, 32:585-589.
34. Phillips L., Appleton R.E. Systematic review of melatonin treatment in children with neurodevelopmental disabilities and sleep impairment. Dev Med Child Neurol 2004, 46:771-775.
35. Wassmer E., Whitehouse W.P. Melatonin and sleep in children with neurodevelopmental disabilities and sleep disorders. Curr Pediatr 2006, 16:132-138.
36. Sajith S.G., Clarke D. Melatonin and sleep disorders associated with intellectual disability: a clinical review. J Intellect Disabil Res 2007, 51:2-13.
37. Braam W., Smits M.G., Didden R., Korzilius H., van Geijlswijk I.M., Curfs L.M.G. Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis. Dev Med Child Neurol 2009, 51:340-349.
38. Chamberlain R.S., Herman B.H. A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism. Biol Psychiatry 1990, 28:773-793.
39. Lord C. What is melatonin? Is it a useful treatment for sleep problems in autism?. J Autism Dev Disord 1998, 28:345-346.
40. Wasdell M.B., Jan J.E., Bomben M.M., Freeman R.D., Rietveld W.J., Tai J., et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res 2008, 44:5-64.
41. Jan J.E., Espezel H., Appleton R.E. The treatment of sleep disorders with melatonin. Dev Med Child Neurol 1994, 36:97-107.
42. Wright B., Sims D., Smart S., Alwazeer A., Alderson-Day B., Allgar V., et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: a randomised controlled crossover trial. J Autism Dev Disord 2010, 41:175-184.
43. Hayashi E. Effect of melatonin on sleep-wake rhythm: the sleep diary of an autistic male. Psychiatry Clin Neurosci 2000, 54:383-384.
44. Jan J.E., Freeman R.D., Wasdell M.B., Bomben M.M. A child with severe night terrors and sleep-waking responds to melatonin therapy. Dev Med Child Neurol 2004, 46:787-789.
45. Horrigan J.P., Barnhill L.J. More on melatonin. J Am Acad Child Adolesc Psychiatry 1997, 36:1014.
46. Gupta R., Hutchins J. Melatonin: a panacea for desperate parents? (Hype or truth). Arch Dis Child 2005, 90:986-987.
47. Andersen I., Kaczmarska J., McGrew S., Malow B. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol 2008, 23:482-485.
48. Galli-Carminati G., Deriaz N., Bertschy G. Melatonin in the treatment of chronic sleep disorders in adults with autism: a retrospective study. Swiss Med Wkly 2009, 139:293-296.
49. Paavonen E.J., Nieminen-von Wendt T., Vanhala R., Aronen E.T., von Wendt L. Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J Child Adolesc Psychopharmacol 2003, 13:83-95.
50. Ackerstedt T., Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci 1990, 52:29-37.
51. Achenbach T.M. Child behavior check list/4-18 1991, University of Vermont, Burlington.
52. Bölte S., Dickhut H., Poustka F. Patterns of parent-reported problems indicative in autism. Psychopathology 1999, 32:93-97.
53. Duarte C.S., Bordin I.A., de Oliveira A., Bird H. The CBCL and the identification of children with autism and related conditions in Brazil: pilot findings. J Autism Dev Disord 2003, 33:703-707.
54. Giannotti F., Cortesi F., Cerquiglini A., Bernabei P. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J Autism Dev Disord 2006, 36:741-752.
55. Owens J.A., Spirito A., McGuinn M., Nobile C. Sleep habits and sleep disturbance in elementary school-aged children. J Dev Behav Pediatr 2000, 21:27-36.
56. Wirojanan J., Jacquemont S., Diaz R., Bacalman S., Anders T.F., Hagerman R.J., et al. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med 2009, 5:145-150.
57. Lord C., Rutter M., DiLavore P.C., Risi S. ADOS. Autism diagnostic observation schedule 2003, Western Psychological Services, Los Angeles.
58. Rutter M., Le Couteur A., Lord C. ADI-R. Autism diagnostic interview revised 2003, Western Psychological Services, Los Angeles.
59. Einfield S.L., Tonge B.J. The developmental behaviour checklist 1989, Monash University Center for Developmental Psychiatry, Melbourne.
60. Goldberg D. General health questionnaire (GHQ-12) 1992, Nfer-Nelson, Windsor (U.K.).
61. Guénolé F., Baleyte J.M. Effectiveness of melatonin for sleep problems in autism spectrum disorders: evidence grows but research is still needed. J Autism Dev Disord 2010, 10.1007/s10803-010-1111-y.
62. Evidence-based medicine working group Evidence-based medicine: a new approach to teaching the practice of medicine. J Am Med Assoc 1992, 268:2420-2425.
63. Charman T. Autism and the pervasive developmental disorders. Curr Opin Neurol 1999, 12:155-159.
64. Walker D.R., Thompson A., Zwaigenbaum L., Goldberg J., Bryson S.E., Mahoney W.J., et al. Specifying PDD-NOS: a comparison of PDD-NOS, Asperger syndrome, and autism. J Am Acad Child Adolesc Psychiatry 2004, 43:172-182.
65. Regier D.A. Dimensional approaches to psychiatric classification: refining the research agenda for DSM-V: an introduction. Int J Methods Psychiatr Res 2007, 16(Suppl. 1):S1-S5.
66. Skuse D.H. Endophenotypes and child psychiatry. Br J Psychiatry 2001, 178:395-396.
67. Principles and practice of sleep medicine 2005, Elsevier Saunders, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
68. American Academy of Sleep Medicine The international classification of sleep disorders 2005, American Academy of Sleep Medicine, Chicago. 2nd ed.
69. Sheldon S.H., Ferber R., Kryger M.H. Practice and principles of pediatric sleep medicine 2005, Elsevier Saunders, Philadelphia.
70. O'Brien L.M. The neurocognitive effects of sleep disruption in children and adolescents. Child Adolesc Psychiatr Clin N Am 2009, 18:813-823.
71. Schopler E., Reichler R.J., DeVellis R.F., Daly K. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J Autism Dev Disord 1980, 10:91-103.
72. Brinkley J., Nations L., Abramson R.K., Hall A., Wright H.H., Gabriels R., et al. Factor analysis of the aberrant behavior checklist in individuals with autism spectrum disorders. J Autism Dev Disord 2007, 37:1949-1959.
73. Waters E., Davis E., Ronen G.M., Rosenbaum P., Livingston M., Saigal S. Quality of life instruments for children and adolescents with neurodisabilities: how to choose the appropriate instrument. Dev Med Child Neurol 2009, 51:660-669.
74. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
75. Honey E., Hastings R.P., McConachie H. Use of the questionnaire on resources and stress (QRS-F) with parents of young children with autism. Autism 2005, 9:246-255.
76. Epstein L.B., Baldwin L.M., Bishop D.S. The McMaster family assessment device. J Marital Fam Ther 1983, 9:171-180.
77. Jan J.E., Hamilton D., Seward N., Fast D.K., Freeman R.D., Laudon M. Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders. J Pineal Res 2000, 29:34-39.
78. Tzischinsky O., Lavie P. Melatonin possesses a time-dependent hypnotic effect. Sleep 1994, 17:638-645.
79. Luboshizsky R., Lavie P. Sleep-inducing effects of exogenous melatonin administration. Sleep Med Rev 1998, 2:191-202.
80. Stone B.M., Turner C., Mills S.L., Nicholson A.N. Hypnotic activity of melatonin. Sleep 2000, 23:663-669.
81. Zhdanova I.V. Melatonin as a hypnotic: pro. Sleep Med Rev 2005, 9:51-65.
82. Ekmekcioglu C. Melatonin receptors in humans: biological role and clinical relevance. Biomed Pharmacother 2006, 60:97-108.
83. Wang F., Li J., Wu C., Jang J., Xu F., Zhao Q. The GABA(A) receptor mediates the hypnotic activity of melatonin in rats. Pharmacol Biochem Behav 2003, 74:573-578.
84. Arendt J., Skene D.J. Melatonin as a chronobiotic. Sleep Med Rev 2005, 9:25-39.
85. Sheldon S.H. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998, 351:1254.
86. Carr R., Wasdell M.B., Hamilton D., Weiss M.D., Freeman R.D., Tai J., et al. Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders. J Pineal Res 2007, 43:351-359.
87. Hoebert M., van der Heijden K.B., van Geijlswijk I.M., Smits M.G. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res 2009, 47:1-7.
88. Srinivasan V., Spence W.D., Pandi-Perumal S.R., Zakharia R., Bhatnagar K.P., Brzezinski A. Melatonin and human reproduction: shedding light on the darkness hormone. Gynecol Endocrinol 2009, 25:779-785.
89. Carrillo-Vico A., Guerrero J.M., Lardone P.J., Reiter R.J. A review of the multiple actions of melatonin on the immune system. Endocrine 2005, 27:189-200.
90. Mody S.M., Hu Y., Ho M.K., Wong Y.H. In search of novel and therapeutically significant melatoninergic ligands. Recent Pat CNS Drug Discov 2007, 2:241-245.